Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMGNC6T)

Drug Name
M-0011 Drug Info
Synonyms N-0011; RhLAMAN, Zymenex; Recombinant human alpha-mannosidase (alpha mannosidosis), Zymenex
Indication
Disease Entry ICD 11 Status REF
Alpha-mannosidosis 5C56.21 Phase 3 [1]
Cross-matching ID
TTD Drug ID
DMGNC6T

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Alpha-mannosidase (MANA) TTT2KE3 MA2B1_HUMAN; MA2B2_HUMAN; MA2C1_HUMAN Modulator [2]

References

1 ClinicalTrials.gov (NCT01908712) Lamazym Aftercare Study FR. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT01681953) A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis. U.S. National Institutes of Health.